Table 2 Radiomics and texture analysis in CMR
From: Machine learning in cardiovascular magnetic resonance: basic concepts and applications
Author | Myocardial disease | Image substrate | Application |
|---|---|---|---|
Beliveau, P. et al., 2015 (Ref 63) | Myocardial fibrosis (rat model) | LGE | Detection of age-related myocardial fibrosis (correlation to histopathology) |
Engan, K. et al., 2010 (Ref 60) | Myocardial infarction | LGE | Discrimination of patients with low risk of arrhythmias from those with high risk of arrhythmias |
Kotu, L.P. et al., 2013 (Ref 61) | Myocardial infarction | LGE | Automated segmentation of scarred tissue areas |
Kotu, L.P. et al., 2013 (Ref 62) | Myocardial infarction | LGE | Enhanced visualization and segmentation of scarred myocardium |
Larroza, A. et al., 2017 (Ref 64) | Myocardial infarction | LGE, Cine | Differentiation between acute and chronic MI (AUC 0.86 for LGE, 0.82 for Cine) |
Baeßler, B. et al., 2018 (Ref 53) | Myocardial infarction | Cine | Differentiation between normal myocardium and small (AUC 0.92) as well as large scar (AUC 0.93) |
Larroza, A. et al., 2018 (Ref 65) | Myocardial infarction | Cine | Differentiation between nonviable, viable, and remote myocardial segments; extraction of TA features over the entire cardiac cycle; AUC 0.85 |
Schofield, R. et al., 2016 (Ref 66) | Hypertrophic heart (hypertrophic cardiomyopathy, amyloid, aortic stenosis) | Cine | Differentiation amongst several causes of myocardial hypertrophy (HCM, amyloid and aortic stenosis) and healthy controls |
Thornhill, R.E. et al., 2014 (Ref 67) | Hypertrophic cardiomyopathy | LGE | Differentiation between segments with and without hypertrophy and fibrosis |
Baeßler, B. et al., 2018 (Ref 68) | Hypertrophic cardiomyopathy | Native T1-weighted | Differentiation between HCM patients and controls (AUC 0.95) |
Cheng, S. et al., 2018 (Ref 69) | Hypertrophic cardiomyopathy | LGE | Association of adverse events in HCM patients with systolic dysfunction with increased LGE heterogeneity |
Neisius, U. et al., 2018 (Ref 70) | Hypertensive heart disease, hypertrophic cardiomyopathy | Native T1 map | Discrimination between hypertensive heart disease and HCM patients with incremental value over global native T1 mapping |
Baeßler, B. et al., 2018 (Ref 71) | Acute myocarditis | Native T1 mapping, T2 mapping | Diagnosis of biopsy-proven acute infarctlike myocarditis (AUC 0.88) |
Baeßler, B. et al., 2017 (Ref 72) | Dilated cardiomyopathy-like myocarditis | Native T1 mapping, T2 mapping | Diagnosis of biopsy-proven acute myocarditis presenting with symptoms of heart failure |